Birken Sarah A, Peluso Alexandra G, Shalowitz David I, Isom Scott, Wagi Cheyenne R, Randazzo Aliza, Falk Derek, Strom Carla, Bell Ronny, Weaver Kathryn E
Department of Implementation Science, Wake Forest School of Medicine, Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.
Department of Implementation Science, Wake Forest School of Medicine, Winston-Salem, NC.
JCO Oncol Pract. 2025 Jun;21(6):766-772. doi: 10.1200/OP.23.00699. Epub 2024 May 22.
Cancer survivors experience better outcomes when primary care providers (PCPs) are engaged in their care. Nearly all survivors have a PCP engaged in their care in the initial 5 years postdiagnosis, but little is known about sustained PCP engagement. We assessed PCP engagement in survivors' care 5-7 years postdiagnosis and characterized survivors most vulnerable to loss to PCP follow-up.
We linked electronic health record ambulatory care and cancer registry data from an National Cancer Institute-Designated Comprehensive Cancer Center to identify eligible survivors (≥18 years; diagnosed with breast, colorectal, or uterine cancer; had an in-network PCP). We used multiple logistic regression to assess associations between survivor demographics, clinical factors, and health care utilization and odds of sustained PCP engagement.
In 5-7 years postdiagnosis, PCPs were engaged in care for 43% of survivors. Survivors with sustained PCP-engagement were on average 4.6 years older than those without ( < .0001); survivors had 1.36 greater odds of having regular PCP visits for each decade increase in age on cancer diagnosis ( = .0030). Survivors were less likely to be lost to PCP follow-up if diagnosed at an earlier stage with odds at 0.57 and 0.10 for stage I and stage IV, respectively ( = .0005), and had 2.70 greater odds of engagement in care with at least one oncology visit annually 5-7 years postdiagnosis ( < .0001).
Sustained PCP engagement is endorsed as critical by survivors, PCPs, and oncologists. We found most survivors were lost to PCP follow-up 5-7 years postdiagnosis. Our study is among the first to contribute empirical evidence of survivors being lost in transition. Findings from this study demonstrate the need to bridge gaps in long-term care for cancer survivors.
当初级保健提供者(PCP)参与癌症幸存者的护理时,他们会有更好的治疗结果。几乎所有幸存者在确诊后的最初5年内都有PCP参与其护理,但对于PCP的持续参与情况知之甚少。我们评估了确诊后5至7年PCP对幸存者护理的参与情况,并确定了最易失去PCP随访的幸存者特征。
我们将来自一家美国国立癌症研究所指定的综合癌症中心的电子健康记录门诊护理数据和癌症登记数据相链接,以确定符合条件的幸存者(≥18岁;诊断为乳腺癌、结直肠癌或子宫癌;有网络内的PCP)。我们使用多元逻辑回归来评估幸存者人口统计学、临床因素、医疗保健利用情况与PCP持续参与几率之间的关联。
在确诊后的5至7年里,43%的幸存者有PCP参与护理。持续有PCP参与护理的幸存者平均比没有的大4.6岁(P <.0001);癌症确诊时年龄每增加十岁,幸存者进行定期PCP就诊的几率就高出1.36倍(P =.0030)。如果在早期阶段确诊,幸存者失去PCP随访的可能性较小,I期和IV期的几率分别为0.57和0.10(P =.0005),并且在确诊后5至7年每年至少进行一次肿瘤就诊的情况下,参与护理的几率高出2.70倍(P <.0001)。
幸存者、PCP和肿瘤学家都认可PCP的持续参与至关重要。我们发现大多数幸存者在确诊后5至7年失去了PCP随访。我们的研究是最早提供幸存者在过渡过程中失去随访的实证证据的研究之一。这项研究的结果表明需要弥合癌症幸存者长期护理中的差距。